n-3 PUFA (n = 15) | Placebo (n = 15) | |
---|---|---|
N | 15 | 15 |
Sex (male/female) | 8/7 | 4/11 |
Age (years) | 50.47 ± 6.06 | 50.67 ± 6.70 |
Diabetes Duration (years) | 6 (2–15) | 8 (1–25) |
Drug Treatment (n) | ||
Diet only | 3 | 3 |
Oral hypoglicemic agents | ||
Metformin | 8 | 4 |
Sulfonylureas | 3 | 0 |
Combined | 1 | 8 |
Antihypertensive (n) | ||
Yes/No | 5/10 | 8/7 |
Weight (kg) | 77.27 ± 11.65 | 72.49 ± 7.66 |
Height (m) | 1.65 ± 0.08 | 1.59 ± 0.09 |
Body Mass Index (kg.m− 2) | 28.22 ± 2.95 | 28.81 ± 4.10 |
Body fat (%) | 32.93 ± 8.88 | 33.79 ± 10.07 |
Waist-to-hip ratio | ||
Men | 0.97 ± 0.05a | 0.88 ± 0.05 |
Women | 0.83 ± 0.08 | 0.87 ± 0.05 |
VO2peak (ml/kg/.min) | 22.87 ± 5.42 | 22.10 ± 6.87 |
Maximal heart rate (bpm) | 151.13 ± 20.29 | 153.87 ± 19.98 |